title: Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
abstract: The GH receptor (GHR) is a member of the cytokine/hematopoietic growth factor family, and protein tyrosine phosphorylation has been implicated in the signaling cascade of these receptors. It was recently shown that the tyrosine kinase JAK2 is associated with the GHR. GH induces the activation of JAK2, which phosphorylates itself and the receptor. Mitogen-activated protein (MAP) kinase activation and transcriptional stimulation of specific genes, such as Spi 2.1, have also been reported to be induced by GH. To identify functionally important regions in the cytoplasmic domain of the GHR, we compared the actions of the wild-type receptor, two truncated mutants, and one internal deletion mutant (similar to the intermediate Nb2 form of the PRL receptor) in transfectants of the Chinese hamster ovary cell line. A region of 46 amino acids adjacent to the membrane was found to be sufficient for activation of both JAK2 and MAP kinases. This region contains a proline-rich sequence (box 1) conserved in the cytokine receptor family that is important for signal transduction. For transcriptional activity, the C-terminal region of the GHR is required, and we found that the last 80 terminal residues contain sequences allowing activation of the Spi 2.1 promoter. Tyrosine phosphorylation of the receptor also requires the C-terminal portion of the GHR cytoplasmic domain, and we found that GHR tyrosine phosphorylation appears to be linked to activation of the Spi 2.1 transcription pathway. Thus, the GHR could be composed of at least 2 functional regions: the 46 proximal amino acids required for activation of JAK2 and sufficient to stimulate the MAP kinase pathway, and an additional carboxy-terminal region necessary for transcriptional activation.
authors.affiliation: INSERM U-344, Faculté de Médecine Necker, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Sotiropoulos
authors.forename: M
authors.initials: M
authors.lastname: Perrot-Applanat
authors.forename: H
authors.initials: H
authors.lastname: Dinerstein
authors.forename: A
authors.initials: A
authors.lastname: Pallier
authors.forename: M C
authors.initials: MC
authors.lastname: Postel-Vinay
authors.forename: J
authors.initials: J
authors.lastname: Finidori
authors.forename: P A
authors.initials: PA
authors.lastname: Kelly
mesh_terms: D000818:Animals; D001483:Base Sequence; D015153:Blotting, Western; D016466:CHO Cells; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000235:genetics / Q000378:metabolism; D006224:Cricetinae; D003593:Cytoplasm / Q000737:chemistry / Q000502:physiology / Q000648:ultrastructure; D004247:DNA / Q000032:analysis / Q000235:genetics; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D017353:Gene Deletion; D053614:Janus Kinase 2; D008934:Mitogens / Q000494:pharmacology*; D008969:Molecular Sequence Data; D009154:Mutation; D010766:Phosphorylation; D011233:Precipitin Tests; D011401:Promoter Regions, Genetic / Q000235:genetics; D011505:Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism*; D011518:Proto-Oncogene Proteins; D011817:Rabbits; D011986:Receptors, Somatotropin / Q000032:analysis / Q000502:physiology*; D014158:Transcription, Genetic / Q000187:drug effects / Q000502:physiology*; D015533:Transcriptional Activation / Q000187:drug effects / Q000502:physiology*; D014443:Tyrosine / Q000378:metabolism
chemical_list: D008934:Mitogens; D011518:Proto-Oncogene Proteins; D011986:Receptors, Somatotropin; D014443:Tyrosine; D004247:DNA; D011505:Protein-Tyrosine Kinases; D053614:Janus Kinase 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases